UTI-lizer
Signal active
Organization
Contact Information
Overview
UTI-lizer is a non-optimal treatment and unnecessary use of antibiotics. They detect bacteria in the clinically relevant range, without any complicated lab instruments. They provide biotechnology research. The contact modes are by mail, phone, and physical address.
About
Industries
Biotechnology, Medical, Medical Device
Founded
2021
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
UTI-lizer headquartered in Europe, operates in the Biotechnology, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $16.1M in funding across 24 round(s). With a team of 1-10 employees, UTI-lizer is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - UTI-lizer, raised $670.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
2
Lead Investors
0
Total Funding Amount
$670.0K
Details
1
UTI-lizer has raised a total of $670.0K in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 670.0K |
Investors
UTI-lizer is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Gustav Notander | - | FUNDING ROUND - Gustav Notander | 670.0K |
| Almi Invest | - | FUNDING ROUND - Almi Invest | 670.0K |
| UTI-lizer | - | FUNDING ROUND - UTI-lizer | 670.0K |
| Propel Capital | - | FUNDING ROUND - Propel Capital | 670.0K |
Recent Activity
There is no recent news or activity for this profile.